Composition, pharmaceutical composition, use of a stable topical composition comprising a nanoemulsion and of at least one antileishmanial compound, and method for the treatment of cutaneous leishmaniasis
US-2024016826-A1 · Jan 18, 2024 · US
US9669044B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9669044-B2 |
| Application number | US-201414281659-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 19, 2014 |
| Priority date | Dec 14, 2010 |
| Publication date | Jun 6, 2017 |
| Grant date | Jun 6, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to novel fungicidal compound including an aminoglycoside analog having certain substituents at the 6 position of ring III that exhibit improved antifungal activity but possess minimal antibacterial properties in combination with fungicidal azoles. The aminoglycoside compounds are analogues of kanamycin A. Also provided are methods of synthesizing and methods of using the compounds of the present invention. The compounds of the present invention are useful in treating or preventing fungal disease.
Opening claim text (preview).
What is claimed is: 1. A fungicidal composition comprising: an aminoglycoside compound, or salt thereof having the formula: wherein: X is a member selected from the group consisting of O and S; R 1 is a member selected from the group consisting of R 3 , C(O)OR 3 , S(O) 2 R 3 , S(O) 2 R 4 , S(O)R 3 , P(O) 2 R 3 , and phenyl, wherein phenyl groups may be C 1 to C 6 alkyl substituted; R 3 is a straight or branched chain C 6 to C 12 alkyl group; and R 4 is phenyl or C 1 to C 6 alkyl substituted phenyl; and an azole. 2. The composition according to claim 1 , wherein: X is O or S; R 1 is a member selected from the group consisting of S(O) 2 R 3 and S(O) 2 R 4 , wherein: R 3 is C 6 to C 12 straight or branched chain alkyl and R 4 is phenyl or C 1 to C 6 alkyl substituted phenyl. 3. The composition according to claim 1 , wherein R 1 is C(O)OR 3 . 4. The composition according to claim 1 , wherein R 1 is S(O)R 3 . 5. The composition according to claim 1 , wherein R 1 is P(O) 2 R 3 . 6. The composition according to claim 2 , wherein X is O and R 1 is S(O) 2 R 3 . 7. The composition according to claim 6 , wherein R 3 is C 6 H 13 . 8. The composition according to claim 6 , wherein R 3 is C 8 H 17 . 9. The composition according to claim 2 , wherein X is O and R 1 is S(O) 2 R 4 . 10. The composition according to claim 9 , wherein R 4 is p-tolyl. 11. The composition according to claim 2 , wherein X is S and R 1 is R 3 . 12. The composition according to claim 11 , wherein R 3 is C 8 H 17 . 13. The composition according to claim 1 , wherein the azole is selected from the group consisting of itraconazol, fluconazole, voriconazole, posaconazole, clotrimazol, tioconazole, ketoconazole, metconazole, tebuconazole, and pyraclostrobin. 14. A method of treating a fungal infection which comprises administering to a host in need thereof an effective amount of a fungicidal composition comprising: an aminoglycoside compound, or salt thereof having the formula: wherein: X is a member selected from the group consisting of O and S; R 1 is a member selected from the group consisting of R 3 , C(O)OR 3 , S(O) 2 R 3 , S(O) 2 R 4 , S(O)R 3 , P(O) 2 R 3 , and phenyl, wherein phenyl groups may be C 1 to C 6 alkyl substituted; R 3 is a straight or branched chain C 6 to C 12 alkyl group; and an azole. 15. The method according to claim 14 wherein: X is O or S; R 1 is a member selected from the group consisting of S(O) 2 R 3 and S(O) 2 R 4 , R 3 is C 6 to C 12 straight or branched chain alkyl, and R 4 is phenyl or C 1 to C 6 alkyl substituted phenyl. 16. The method according to claim 15 wherein X is O and R 1 is S(O) 2 R 3 . 17. The method according to claim 16 wherein R 3 is C 6 H 13 . 18. The method according to claim 16 wherein R 3 is C 8 H 17 . 19. The method according to claim 14 wherein said host in need thereof is a plant or an animal. 20. The method of claim 14 , wherein the azole is selected from the group consisting of itraconazole, fluconazole, voriconazole, posaconazole, clotrimazole, tioconazole, ketoconazole, metconazole, tebuconazole, and pyraclostrobin.
Lactones · CPC title
with oxygen as the ring hetero atom · CPC title
1,2,4-Triazoles · CPC title
1,2-Diazoles · CPC title
Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.